We examined these questions by using the model of trophic factor deprivation in sympathetic neurons. Neonatal sympathetic neurons require nerve growth factor (NGF) for their survival (Levi-Montalcini and Booker, 1960; Gorin and Johnson, 1979; Crowley et al., 1994) . In the absence of NGF these neurons undergo an apoptotic cell death (Edwards et al., 1991; Deckwerth and Johnson, 1993) , which requires de novo protein synthesis (Martin et al., 1988) and the development of competence-to-die (Deshmukh and Johnson, 1998) . This death is inhibited by caspase inhibitors (Troy et al., 1996; McCarthy et al., 1997) , such as boc-aspartyl(OMe)-fluoromethylketone (BAF) (Deshmukh et al., 1996) , and neuroprotective agents, such as KCl and cAMP (Rydel and Greene, 1988; Koike et al., 1989; Edwards et al., 1991; Deckwerth and Johnson, 1993; Franklin et al., 1995) . Most important, in contrast to other model systems in which BAX translocation has been studied, sympathetic neurons absolutely require the endogenous expression of Bax to undergo apoptosis induced by trophic factor deprivation . However, because neither the mRNA nor protein level of BAX increases during NGF deprivation-induced apoptosis, BAX must be regulated post-translationally (Greenlund et al., 1995) .
Here we report that NGF-deprived sympathetic neurons induced macromolecular synthesis-dependent, caspase-independent subcellular redistribution of BAX, followed by the loss of mitochondrial cytochrome c, caspase activation, and apoptosis. Neuroprotective agents, such as KCl and cAMP, blocked the redistribution of both BAX and cytochrome c when added at the time of deprivation but prevented only cytochrome c release when administered 12 hr after NGF withdrawal. Overexpression of Bcl-2 neither altered the normal subcellular localization of BAX nor prevented its redistribution with deprivation but did inhibit the subsequent release of cytochrome c, caspase activation, and cell death. These findings indicate that the subcellular redistribution of BAX is a critical event in neuronal apoptosis induced by trophic factor deprivation. Although BCL-2 acted primarily, if not exclusively, at the level of mitochondria to prevent BAX-mediated cytochrome c release, neuroprotective agents such as KCl or cAMP aborted the apoptotic program at multiple checkpoints.
MATERIALS AND METHODS
Reagents. All reagents were purchased from Sigma (St. L ouis, MO) unless otherwise stated. Collagenase and trypsin were purchased from Worthington Biochemical (Freehold, NJ). The caspase inhibitor, bocaspartyl(OMe)-fluoromethylketone (BAF), was purchased from Enzyme Systems Products (Livermore, CA). The membrane-permeable cAM P analog, 8-(4-chlorophenylthio)-adenosine 3Ј:5Ј-cyclic monophosphate (C P T-cAM P), was used as the source of cAM P. C M1 polyclonal antibody, a gift from Dr. Anu Srinivasan (Idun Pharmaceuticals, La Jolla, CA), was raised against the 13-amino-acid peptide CRGTELDCGI ETD, which is found at the C terminus of the p20 subunit of caspase-3 Namura et al., 1998; Srinivasan et al., 1998b) . Medium lacking NGF (AM0) consisted of Eagle's M EM with Earl's salts (Life Technologies, Gaithersburg, MD) supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin, 100 g /ml streptomycin, 20 M fluorodeoxyuridine, 20 M uridine, and 3.3 g /ml aphidicolin. AM50 medium consisted of AM0 medium plus 50 ng /ml mouse 2.5S NGF (Harlan Bioproducts, Indianapolis, I N). The breeding and genotyping of Bcl-2-overexpressing and Ba x-deficient mice have been described previously (Martinou et al., 1994; Knudson et al., 1995; Deckwerth et al., 1996) .
Sympathetic neuronal cultures. Primary cultures of sympathetic neurons were established from the superior cervical ganglia of neonatal mice by using a modification of a previously described method (Johnson et al., 1983; Deckwerth et al., 1996; Easton et al., 1997) . Briefly, the dissected ganglia were treated with collagenase (1 mg /ml) and then trypsin (2.5 mg /ml) for 30 min each at 37°C. The ganglia were triturated, and the dissociated cells were plated on collagen-coated dishes in AM50.
We observed that neurons from inbred C57BL /6 mice exhibited a loss of mitochondrial cytochrome c and commitment-to-die ϳ4 -6 hr earlier than neurons from Sprague Dawley rats or outbred ICR mice (see Figs. 1e, 5a; Deckwerth and Johnson, 1993; Deshmukh and Johnson, 1998) . We believe that these shifts may be attributable to species and strain differences. Unless indicated otherwise, all control experiments were conducted with C57BL /6 mice, the background strain for both the Ba x-deficient and Bcl-2 transgenic mice.
Culture conditions. Sympathetic neuronal cultures were grown in AM50 for 4Ϫ5 d and then either maintained in AM50 or treated as follows. For NGF deprivation the cultures were rinsed with AM0, followed by the addition of AM0 containing goat anti-mouse 2.5S NGF neutralizing antiserum (anti-NGF) (Ruit et al., 1990) . For NGF deprivation in the presence of various reagents, 1 g /ml cycloheximide, 40 mM KC l, 400 M C P T-cAM P, or 50 M BAF was added to AM0 containing anti-NGF. For acute rescue experiments in which NGF, KC l, or C P TcAM P was readded to cultures after 12 hr of NGF deprivation, the cultures were rinsed with AM0 and then incubated in AM0 medium containing 300 ng /ml NGF, 40 mM KC l, or 400 M C P T-cAM P, each in the presence of 50 M BAF.
Immunoc ytochemistr y. Neuronal cultures were immunostained as described previously (Easton et al., 1997; Deshmukh and Johnson, 1998) . Briefly, sympathetic neurons (1500Ϫ3000 cells) were grown on collagencoated two-well glass chamber slides (Nalge Nunc, Naperville, IL) in the appropriate medium. Cultures were washed with PBS and fixed with freshly prepared 4% paraformaldehyde in PBS (PFA) for 30 min at 4°C. Cultures then were washed with PBS and Tris-buffered saline (TBS; 100 mM Tris-HC l and 0.9% NaC l, pH 7.6), exposed to blocking solution [TBS containing 5% donkey serum (Chemicon, Temecula, CA) and 0.3% Triton X-100] for 30 min at room temperature (RT) and incubated in the appropriate primary antibody diluted in TBS, 1% donkey serum, and 0.3% Triton X-100 at 4°C overnight. Cultures then were washed with TBS and incubated for 2-4 hr at 4°C in the dark with the appropriate secondary antibody diluted in TBS, 1% donkey serum, and 0.3% Triton X-100. Cultures were washed with TBS and stained with 1 g /ml bisbenzimide (Hoechst 33258; Molecular Probes, Eugene, OR) for 15Ϫ20 min at RT. After being rinsed with TBS, the cultures were coverslipped and examined by fluorescence microscopy. Phospho-c-Jun, Fos, and activated caspases 3 and 7 were detected with the following rabbit polyclonal antibodies at the indicated dilutions: anti-phospho-c-Jun (Ser63) (1:200; New England Biolabs, Beverly, M A), anti-Fos (1:3000; Santa Cruz Biotechnology, Santa Cruz, CA) and C M1 (1:5000; Idun Pharmaceuticals, La Jolla, CA). The secondary antibody was a C y3-conjugated donkey anti-rabbit IgG (1.5 mg /ml; Jackson ImmunoResearch, West Grove, PA) diluted 1:400. C ytochrome c (1:1000; PharMingen, San Diego, CA), cytochrome oxidase V Ic (1:500; Molecular Probes), and human and mouse BCL -2 (1:250; PharMingen) were detected with mouse monoclonal primary antibodies and FI TC -conjugated donkey anti-mouse secondary antibody (0.6 mg /ml; Jackson ImmunoResearch) diluted 1:300.
BAX was detected with a rat monoclonal primary antibody (1:250; PharMingen) and a C y3-conjugated anti-rat secondary antibody (1.5 mg /ml; Jackson ImmunoResearch) diluted 1:400. Several antibodies to BAX, both commercial and proprietary, were tested for specificity in our system. All of the BAX antibodies that we tested stained tissues from Ba x-deficient mice. However, the faint, diff use staining pattern seen in Ba x Ϫ/Ϫ sympathetic neurons with the PharMingen antibody used in these studies did not change during NGF deprivation.
Cell counts: commitment point e xperiments. Sympathetic neurons from Bcl-2 transgenic mice and their wild-type littermates were deprived of NGF as described above. At various times after deprivation the cultures were rinsed with AM0 and then incubated in AM50 for 5Ϫ7 d. Neurons then were counted after being washed with PBS, fixed with freshly prepared 4% PFA for 30 min at 4°C, washed again with PBS, and stained with toluidine blue as described previously (Deckwerth and Johnson, 1993; Deshmukh et al., 1996) .
Cell counts: BA X and c ytochrome c immunoc ytochemistr y. Sympathetic neurons that had been maintained in NGF for 4 -5 d in AM50 were deprived of NGF in the presence of the caspase inhibitor BAF (as described above). At various times after deprivation or acute rescue by readdition of NGF, KC l, or C P T-cAM P the cultures were fixed and immunostained with anti-BAX and /or anti-cytochrome c antibodies. NGF-maintained sympathetic neurons exhibited diff use BAX and punctate cytochrome c staining patterns. With NGF deprivation the cells showed punctate BAX and diff use cytochrome c staining patterns. For each time point the number of cells that had acquired a punctate staining pattern for BAX or had lost the punctate staining pattern for cytochrome c was determined by a naïve observer from a random sampling of 100 -250 cells. For the double immunocytochemistry experiments the staining patterns for both BAX and cytochrome c were assessed in the same neuron. All experiments were conducted in the presence of BAF to prevent any cell loss that otherwise would affect the counts.
Microinjections and quantitation of cell death. These experiments were performed as described previously (Deshmukh and Johnson, 1998) . Briefly, sympathetic neurons were maintained in NGF for 4 d and treated for 24 -48 hr with NGF, anti-NGF, or anti-NGF plus 1 g /ml cycloheximide. C ells then were microinjected with 5 mg /ml bovine cytochrome c and rhodamine dextran dye. At each time point after the injections the number of microinjected cells that remained viable was determined and expressed as a percentage of the total number of microinjected cells.
Statistics. When indicated, statistical significance was determined by a Student's t test or by a Mann -Whitney Rank Sum test for parametric and nonparametric data, respectively.
RESULTS

BAX undergoes caspase-independent subcellular redistribution after NGF deprivation in sympathetic neurons
Previous studies in several models of programmed cell death (PCD) show that BAX translocates from the cytosol to mitochondria when overexpressed and/or in response to certain death signals Wolter et al., 1997; Eskes et al., 1998; Gross et al., 1998; Rosse et al., 1998; Saikumar et al., 1998; Zhang et al., 1998; Finucane et al., 1999; McGinnis et al., 1999) . We examined whether the translocation of endogenous BAX occurred in NGF-deprived sympathetic neurons. These studies were done in the presence of the caspase inhibitor BAF to prevent any cell death that otherwise might have complicated the determination of cell numbers. BAX redistribution also was observed in the absence of BAF; however, because redistribution was followed very rapidly by cell death in the absence of caspase inhibition, counting cells in the absence of BAF yielded a misleading estimate of the number of cells in which BAX had redistributed (data not shown).
We examined the subcellular localization of BAX by using immunocytochemistry rather than subcellular fractionation because of the impracticality of the latter, given the limited number of primary neurons obtained from each sympathetic ganglion in mice. Recently, two reports (using models of PCD that have not been shown to require endogenous BAX for apoptosis) suggest that BAX in non-neuronal cell lines does not translocate from the cytosol to mitochondria but instead that BAX already at mitochondria undergoes a conformational change that exposes an N-terminal epitope (Goping et al., 1998; Desagher et al., 1999) . The immunocytochemistry results reported here cannot distinguish clearly between these two possibilities because the antibody used recognizes an epitope in the N terminus of BAX. However, because the preponderance of evidence in non-neuronal cell lines (see above) suggests that BAX undergoes translocation to mitochondria and not merely a conformational change at mitochondria, we shall, therefore, refer to the apparent redistribution we observed as translocation.
NGF-maintained sympathetic neurons primarily exhibited a diffuse staining pattern, consistent with a predominantly cytosolic localization for BAX (Fig. 1a) . A small fraction of cells displayed a faint, punctate staining pattern, suggesting that, although BAX normally may reside primarily in the cytosol, a small amount may exist in association with organelle membranes in NGFmaintained cells (data not shown). The pattern of BAX staining was altered in NGF-deprived sympathetic neurons from a diffuse, cytosolic pattern to a punctate pattern, consistent with the redistribution of BAX to intracellular membranes (Fig. 1b) . Punctate BAX staining colocalized extensively with mitochondrial markers, such as cytochrome oxidase subunit V Ic and Mitotracker Orange C M-H 2 TMRos (data not shown). As described previously (Deshmukh and Johnson, 1998; Neame et al., 1998) , NGF deprivation also induced a change in the pattern of cytochrome c staining from a punctate, mitochondrial pattern to a diffuse, cytosolic pattern (Fig. 2b, f, j) .
The time courses for BAX and cytochrome c redistribution after NGF deprivation in sympathetic neurons were determined (see Fig. 1e ). Fifty percent of the neurons exhibited a punctate, mitochondrial BAX staining pattern by 11Ϫ13 hr, with nearly all of the neurons displaying redistribution of BAX by 24 hr. BAX redistribution was followed rapidly, but not instantaneously, by a loss of mitochondrial cytochrome c staining. Fifty percent of the neurons exhibited a diffuse, cytosolic pattern of cytochrome c staining by 14Ϫ16 hr, with essentially all of the cells showing a loss of mitochondrial cytochrome c by 24 hr. The time course with which sympathetic neurons became committed to die (i.e., could not be rescued by NGF readdition) paralleled the time course of cytochrome c release, suggesting that the loss of mitochondrial cytochrome c commits these cells to die (see Figs. 1e, 5; data not shown).
As seen in Figure 1e , BAX redistribution to the mitochondria preceded loss of mitochondrial cytochrome c by 1Ϫ3 hr, suggesting that a transient "state" exists in a sympathetic neuron undergoing NGF deprivation-induced death in which both BAX and cytochrome c show mitochondrial localization. Immunocytochemistry for BAX and cytochrome c confirmed this prediction (Fig. 2) . Sympathetic neurons maintained in NGF existed in "state 1," in which BAX was distributed primarily throughout the cytoplasm and cytochrome c was localized mitochondrially (Fig.  2a-d, m) . After 24 hr of NGF deprivation nearly all of the cells resided in "state 3," with BAX and cytochrome c predominantly localized to the mitochondria and cytosol, respectively (Fig. 2i-m) . However, at an intermediate time point such as 12 hr after deprivation, we found evidence that cells transited through a short-lived "state 2," in which both BAX and cytochrome c were localized mitochondrially (Fig. 2e-h, m) . Thus, NGF deprivation in sympathetic neurons induced a caspase-independent subcellular redistribution of BAX, followed by a loss of cytochrome c from the mitochondria.
Redistribution of BAX and Cytochrome c is inhibited by the neuroprotective agents cycloheximide, cAMP, and KCl
Inhibitors of macromolecular synthesis such as cycloheximide prevent NGF deprivation-induced cell death in sympathetic neurons (Martin et al., 1988) , aborting the PCD pathway upstream of cytochrome c release and caspase activation (Deshmukh and Johnson, 1998; Neame et al., 1998 ) (data not shown). To determine whether de novo protein synthesis was required for the redistribution of BAX during neuronal death, we examined the ability of cycloheximide to block this event. NGF-deprived, cycloheximide-saved neurons maintained a diff use pattern of BAX staining even after 48 hr of NGF deprivation (Fig. 3a) . Accordingly, cycloheximide also prevents the loss of mitochondrial cytochrome c during NGF deprivation (Fig. 3b) (Deshmukh and Johnson, 1998; Neame et al., 1998) .
Although NGF is the physiological survival factor for sympathetic neurons in vivo, several other agents promote their survival in vitro. Of these, two robust neuroprotectants are the cellpermeable cAMP analog, CPT-cAMP, and depolarizing concentrations of KCl (Rydel and Greene, 1988; Koike et al., 1989; Edwards et al., 1991; Deckwerth and Johnson, 1993; Franklin et al., 1995) . Therefore, we examined the effects of these agents on the redistribution of BAX and cytochrome c during sympathetic neuronal death. Even after 48 hr of NGF deprivation in the presence of either KCl (40 mM) or CPT-cAMP (400 M), neurons exhibited minimal redistribution of BAX and cytochrome c (Fig. 3a,b) . Thus, NGF deprivation in sympathetic neurons induced a macromolecular synthesis-dependent, caspase-independent redistribution of BAX and cytochrome c. Potent neuroprotectants, such as KCl and cAMP, prevented both events.
Rescue with NGF, KCl, or cAMP prevents further release of cytochrome c, but only NGF acutely prevents further redistribution of BAX during neuronal death NGF readdition within the first 12 hr after deprivation can fully rescue sympathetic neurons from neonatal rats (Edwards et al., 1991; Deckwerth and Johnson, 1993) . Thereafter, sympathetic neurons start becoming irreversibly committed to die. Only 50% can be rescued by NGF readdition after 22 hr of deprivation; essentially none can be rescued after 48 hr of deprivation. (In neurons from C57BL/6 mice, these time points are shifted ϳ4 -6 hr earlier than in neurons from Sprague Dawley rats; see Materials and Methods.) Like NGF, either KCl, cAMP, or BAF can arrest sympathetic neuronal death post-translationally. Indeed, the time courses with which sympathetic neurons are rescued by NGF, KCl, cAMP, or BAF are indistinguishable (Edwards et al., 1991; Deckwerth and Johnson, 1993; Franklin et al., 1995; Deshmukh et al., 1996) .
As described above, treatment with elevated concentrations of KCl or cAMP at the time of NGF withdrawal prevented the redistribution of BAX and cytochrome c (Fig. 3) . To study the mechanisms by which NGF, KCl, or cAMP arrests sympathetic neuronal death post-translationally, we examined whether treatment with each of these agents 12 hr after NGF withdrawal acutely prevented further redistribution of BAX and cytochrome c. Cells were deprived of NGF in the presence of BAF for 12 hr, and the pattern of BAX or cytochrome c staining was assessed. In parallel cultures NGF, KCl, or cAMP was added back, and the pattern of BAX or cytochrome c staining was determined 12 hr later. As shown in Figure 4b , rescue with NGF, KCl, or cAMP acutely prevented any further loss of mitochondrial cytochrome c in NGF-deprived sympathetic neurons, indicating that each of these agents rapidly can suppress cytochrome c release. However, only NGF, but not KCl or cAMP, prevented the further redistribution of BAX to mitochondria. These results suggested that cAMP and KCl acted after BAX redistributed to mitochondria to prevent cytochrome c release and cell death in sympathetic neurons.
If cells were rescued acutely with NGF and observed 5 d (not 12 hr) later, all cells returned to "state 1" (see Fig. 2 ) in which BAX was diffuse and cytochrome c was punctate (data not shown). We currently are investigating whether this phenomenon reflects reversibility in BAX redistribution or degradation of mitochondrial BAX and de novo synthesis of cytosolic BAX. 
Overexpression of Bcl-2 inhibits cytochrome c release, caspase activation, and cell death, but not BAX redistribution, during sympathetic neuronal death
Sympathetic neurons from Ba x-deficient mice do not undergo apoptosis after NGF deprivation . Similarly, overexpression of Bcl-2 or inhibition of caspases-by either genetic deletion or peptide inhibitors-protects numerous neuronal subpopulations, including sympathetic neurons, from developmental and induced cell death (Martinou et al., 1994; Greenlund et al., 1995; Deshmukh et al., 1996; Kuida et al., 1996 Kuida et al., , 1998 McCarthy et al., 1997; Hakem et al., 1998; Woo et al., 1998) . To compare mechanistically the sites of action for BCL -2, BAX, and caspases, we examined sympathetic neuronal death in transgenic mice overexpressing Bcl-2. These mice, which have been described extensively (Martinou et al., 1994) , overexpress human Bcl-2 behind the neuron-specific enolase promoter, which is expressed from embryonic day 12.5 into adulthood. Western blot analysis confirmed expression of the transgene in sympathetic neurons (data not shown).
To assess the extent of protection afforded by overexpression of Bcl-2, we determined the time course of commitment-to-die in neurons from Bcl-2 transgenic mice. Sympathetic neurons from both transgenic and wild-type mice were deprived of NGF. At various times after deprivation, NGF was readded and cell survival was assessed 5-7 d later. As shown in Figure 5 , Bcl-2 overexpression significantly delayed commitment-to-die from ϳ12 hr to ϳ3 d; however, unlike Ba x deletion, overexpression of Bcl-2 did not prevent NGF deprivation-induced cell death completely in sympathetic neurons. Other studies (e.g., c-Jun phosphorylation and c-fos induction) indicated that Bcl-2 overexpression aborted NGF deprivation-induced cell death at a point that is mechanistically indistinguishable from Ba x deletion (Deckwerth et al., 1998) (data not shown).
Bax deletion prevents the loss of cytochrome c from mitochondria (Deshmukh and Johnson, 1998) . Similarly, overexpression of Bcl-2 or Bcl-X L inhibits cytochrome c release induced by different apoptotic stimuli in several non-neuronal cell lines (K harbanda et al., 1997; Kluck et al., 1997; Yang et al., 1997; Duckett et al., 1998; Srinivasan et al., 1998a; Finucane et al., 1999) . As shown in Figure 6b , Bcl-2 overexpression inhibited the loss of mitochondrial cytochrome c during NGF deprivation in sympathetic neurons. Accordingly, we found that overexpression of Bcl-2 inhibited caspase activation, as determined by staining with the polyclonal antibody CM1, which recognizes activated caspases 3 and 7 (data not shown).
To determine whether overexpression of Bcl-2 affects the subcellular localization of endogenous BAX during cell death, we examined the time course of BAX redistribution in sympathetic neurons from Bcl-2 transgenic mice. As shown in Figure 6a , Bcl-2 Figure 5 . Overexpression of Bcl-2 inhibits NGF deprivation-induced cell death in sympathetic neurons. Neurons from wild-type (OE) and Bcl-2 transgenic (F) mice were maintained in NGF for 5 d and then deprived of NGF for various periods. At 1, 2, 3, or 7 d after deprivation the cells were washed and rescued with 50 ng /ml NGF. Then 5 d later the neurons were fixed, stained with toluidine blue, and counted. Mean Ϯ SEM; n Ն 3. Figure 4 . NGF, KCl, and cAM P differ in their ability to rescue the redistribution of BAX and cytochrome c during sympathetic neuronal death. At 0, 6, 12, 18, or 24 hr after NGF deprivation in the presence of 50 M BAF (F), sympathetic neurons were fixed and immunostained for BAX ( a) or cytochrome c ( b) . In parallel cultures the neurons that were deprived of NGF in the presence of 50 M BAF for 12 hr were washed and rescued with 300 ng/ml NGF (OE), 40 mM KC l (f), or 400 M C P T-cAM P (ࡗ). After an additional 12 hr the number of cells exhibiting punctate BAX or diffuse cytochrome c staining was determined, with 200 -250 cells counted for each time point. In a, the neurons rescued with NGF were statistically different from those rescued with BAF, KC l, or C P T-cAM P ( p Ͻ 0.001). In b, the neurons rescued with BAF were statistically different from those rescued with NGF, KCl, or CPT-cAM P ( p Ͻ 0.001). Mean Ϯ SEM; n Ն 3. overexpression neither prevented nor altered the rate of subcellular redistribution of endogenous BAX after NGF deprivation. We also found that overexpression of Bcl-2 had no obvious effect on the distribution of endogenous BAX in NGF-maintained sympathetic neurons (Fig. 6a, 0 hr; data not shown). Thus, the results shown in Figure 6 indicate that the overexpression of Bcl-2 in sympathetic neurons inhibited cell death induced by NGF deprivation by preventing BAX-mediated cytochrome c release.
Overexpression of Bcl-2 does not inhibit cell death induced by microinjection of cytochrome c
As described above, the overexpression of Bcl-2 did not prevent BAX redistribution, but it did inhibit the loss of mitochondrial cytochrome c and caspase activation (Fig. 6 ). These findings indicate that BCL -2 acted at the level of mitochondria to inhibit NGF deprivation-induced cell death in sympathetic neurons. Recent reports suggest that overexpression of anti-apoptotic BCL-2 family members, such as Bcl-2 and Bcl-X L , can prevent caspase activation and cell death downstream of or independent from cytochrome c release (Li et al., 1997; Rosse et al., 1998) . To determine whether BCL -2 can prevent neuronal death even after cytochrome c translocates to the cytosol, we examined whether overexpression of Bcl-2 inhibited the cell death induced by microinjection of cytochrome c into NGF-deprived sympathetic neurons. Previously, we have shown that microinjection of cytochrome c into NGF-maintained neurons does not induce cell death. However, microinjection of cytochrome c into NGFdeprived, cycloheximide-treated or NGF-deprived, Ba x-deficient neurons induces rapid cell death that is inhibitable by BAF, suggesting that NGF withdrawal induces two parallel processes, both of which are required for cell death: loss of mitochondrial cytochrome c and the development of competence-to-die (Deshmukh and .
As shown in Figure 7 , microinjection of cytochrome c into NGF-deprived, Bcl-2-overexpressing sympathetic neurons in the presence or absence of cycloheximide induced cell death. Furthermore, the extent and time course of death after the injection of cytochrome c was not affected by overexpression of Bcl-2. These findings also indicate that Bcl-2 overexpression -like Bax deletion and cycloheximide treatment-did not prevent the development of competence-to-die. Taken together, the results shown in Figures 6 and 7 indicate that BCL -2 appears to act solely at the level of mitochondria to prevent BAX-mediated cytochrome c release and cell death in NGF-deprived sympathetic neurons.
DISCUSSION BAX and cytochrome c undergo subcellular redistribution during sympathetic neuronal death
Despite the widespread expression of Bax in vivo, Bax-deficient mice exhibit relatively modest defects in non-neuronal lineages, perhaps because of functional redundancy with other proapoptotic BCL-2 family members (Knudson et al., 1995) . In contrast, their phenotype in neuronal lineages, whether central or peripheral, is dramatic Miller et al., 1997; Shindler et al., 1997; White et al., 1998) . For example, despite the coexpression of multiple proapoptotic BCL-2 family members, cell death induced by trophic factor deprivation in sympathetic and motor neurons is remarkably dependent on BAX alone. However, because neither the mRNA nor protein level of BAX increases during NGF deprivation-induced apoptosis in sympathetic neurons (Greenlund et al., 1995) , BAX must be regulated post-translationally.
Recent evidence suggests that this regulation occurs at the level of subcellular localization of BAX. In several models of cell death . Overexpression of Bcl-2 does not prevent cell death induced by cytoplasmic microinjection of cytochrome c into NGF-deprived sympathetic neurons. C ells from wild-type (‚ or OE) or Bcl-2 transgenic (E or F) mice were maintained in NGF for 5 d and treated for 24 -48 hr with NGF (‚), anti-NGF (E), or anti-NGF plus 1 g/ml cycloheximide (CHX; OE and F). Then the cells were microinjected with 5 mg /ml bovine cytochrome c and rhodamine dextran dye. At each time point after the injections the number of microinjected cells that remained viable was determined and expressed as a percentage of the total number of microinjected cells. Mean Ϯ SEM; n Ն 3. the overexpression of Ba x and /or certain death signals induce translocation of BAX from the cytosol to mitochondria Wolter et al., 1997) , followed by cytochrome c release, mitochondrial dysf unction, caspase activation, and cell death Rosse et al., 1998; Saikumar et al., 1998; Zhang et al., 1998; Finucane et al., 1999; McGinnis et al., 1999) . However, to our knowledge, none of these non-neuronal models of PCD requires endogenous Ba x expression for cell death; in fact, a few have been shown specifically not to require BAX (Knudson et al., 1995) . Moreover, Ba x overexpression per se drives mitochondrial translocation (Rosse et al., 1998; our unpublished observations) and induces a cell death that may not require caspases and is not purely apoptotic (X iang et al., 1996) .
Neonatal sympathetic neurons deprived of NGF undergo an apoptotic cell death that requires de novo protein synthesis (Martin et al., 1988) , Ba x expression , and the development of competence-to-die (Deshmukh and Johnson, 1998) . In this study we found that NGF deprivation in sympathetic neurons induced a protein synthesis-dependent, caspaseindependent redistribution of BAX from cytosol to mitochondria (see Figs. 1-3 ). This was followed rapidly, but not instantaneously, by cytochrome c release and commitment-to-die (see Figs. 2, 5) . The identity of the specific gene product(s) induced during NGF deprivation and required for BAX redistribution remains unknown.
Recently, Goping et al. (1998) and Desagher et al. (1999) suggested that BAX does not translocate from the cytosol to mitochondria but instead that BAX already at mitochondria undergoes a conformational change that exposes an N-terminal epitope. The immunocytochemical findings reported here cannot distinguish clearly between the translocation of BAX to mitochondria and a conformational change in BAX at mitochondria. We currently are examining the feasibility of subcellular fractionation experiments to resolve this issue.
The precise mechanism by which BAX mediates loss of mitochondrial cytochrome c is unclear. Recent evidence suggests that two potentially interrelated mechanisms may mediate this release: the calcium-inducible, cyclosporin A (C sA)-sensitive permeability transition pore (P TP) and a Mg 2ϩ -sensitive, CsAinsensitive pathway that depends on BAX (or perhaps more generally on BH3 domain-containing, proapoptotic BCL-2 family members) (Eskes et al., 1998; Marzo et al., 1998; Narita et al., 1998) . If BAX and the PTP mediate two biochemically and molecularly distinct pathways for cytochrome c release, four observations argue against a significant role for the PTP in sympathetic neuronal death. First, primary sympathetic neurons absolutely require BAX alone for cytochrome c release (Deshmukh and Johnson, 1998) , caspase activation, and apoptosis . Second, mitochondria in NGF-deprived neurons do not exhibit the ultrastructural changes such as swelling and outer membrane rupture that should accompany permeability transition (Martin et al., 1988; Martinou et al., 1999) . Third, nontoxic concentrations of CsA neither prevented nor delayed cytochrome c release or cell death induced by NGF deprivation in murine sympathetic neurons (our unpublished observations). Fourth, we find that a significant delay in time occurred between cytochrome c release and the loss of mitochondrial membrane potential (our unpublished observations). Thus, our data suggest that permeability transition does not mediate cytochrome c release during trophic factor deprivation-induced cell death in neurons.
Acute rescue with NGF, but not KCl or cAMP, prevents redistribution of BAX
Cell death induced by NGF deprivation in sympathetic neurons can be arrested late in the apoptotic process by the readdition of NGF (Deckwerth and Johnson, 1993) , KCl (Franklin et al., 1995) , cAMP (Edwards et al., 1991) , or BAF (Deshmukh et al., 1996) . In fact, the time courses with which sympathetic neurons are rescued by NGF, KCl, cAMP, or BAF are indistinguishable. However, BAF, but not NGF, can inhibit sympathetic neuronal death after cytochrome c release and caspase activation (Deshmukh and Johnson, 1998) .
In this study we have identified other important differences in the post-translational mechanisms by which NGF, KCl, cAMP, or BAF aborts NGF deprivation-induced cell death in sympathetic neurons. Specifically, we found that NGF, KCl, or cAMP, but not BAF, prevented redistribution of BAX and cytochrome c when added at the time of deprivation (see Fig. 3 ). Similarly, acute rescue with NGF, KCl, or cAMP, but not BAF, after 12 hr of deprivation prevented further loss of cytochrome c from mitochondria (see Fig. 4b ). However, only NGF acutely prevented further redistribution of BAX (see Fig. 4a ). These observations suggest that KCl or cAMP can act after BAX has redistributed to The identity of the specific gene product, the expression of which may be regulated by c-Jun, is unknown. Although NGF, KCl, or cAM P can block the cell death pathway in sympathetic neurons at multiple checkpoints, only NGF, the physiological survival factor, inhibits apoptosis at all known points before cytochrome c release and caspase activation. mitochondria to prevent cytochrome c release and cell death in sympathetic neurons. Our results cannot exclude the possibility that NGF also may act after BAX translocation to inhibit cytochrome c release. These findings also imply that, although NGF, KCl, or cAM P each can abort the cell death cascade in sympathetic neurons at multiple checkpoints, only NGF, the physiological survival factor, may inhibit apoptosis at all known points before cytochrome c release and caspase activation.
Bcl-2 overexpression prevents redistribution of cytochrome c, but not BAX, during PCD Bax deletion and, to a lesser extent, caspase inhibition protect sympathetic neurons against NGF deprivation-induced apoptosis Deshmukh et al., 1996; Troy et al., 1996; McCarthy et al., 1997) . In this study we found that Bcl-2 overexpression significantly delayed, but did not prevent, sympathetic neuronal death (see Fig. 5 ). Overexpression of Bcl-2 aborted the apoptotic cascade induced by NGF deprivation at a point that is mechanistically indistinguishable from Ba x deletion.
In several non-neuronal cell lines the overexpression of Bcl-2 or Bcl-X L prevents-and Ba x promotes-the translocation of cytochrome c and cell death (K harbanda et al., 1997; K luck et al., 1997; Yang et al., 1997; Gross et al., 1998; Rosse et al., 1998; Finucane et al., 1999) . To examine f urther the actions of BAX and BCL -2 in regulating the loss of cytochrome c from mitochondria in primary neurons, we examined the subcellular localization of BAX and cytochrome c during NGF deprivation in Bcl-2-overexpressing sympathetic neurons. We observed that Bcl-2 overexpression, like Ba x deletion, prevented the loss of mitochondrial cytochrome c to approximately the same extent that it inhibited cell death induced by NGF deprivation (compare Figs. 5, 6b) . We also found that overexpression of Bcl-2 did not prevent-nor did it alter the kinetics of-the subcellular redistribution of endogenous BAX (see Fig. 6a ).
Last, whether BCL -2 or BCL -X L can prevent caspase activation and cell death downstream of or independent from cytochrome c release is unclear (Li et al., 1997; Rosse et al., 1998; Zhivotovsky et al., 1998) . Presumably, this anti-apoptotic activity would be related to the interaction of BCL -2 or BCL-X L with Apaf-1 at the level of the apoptosome (Pan et al., 1998) . However, in NGF-deprived sympathetic neurons in the presence or absence of cycloheximide, we observed that Bcl-2 overexpression neither prevented nor altered the rate of cell death induced by microinjection of cytochrome c (see Fig. 6c ). Taken together, these observations indicate that BCL -2 f unctions primarily, if not exclusively, at the level of mitochondria to inhibit BAX-mediated cytochrome c release.
The role of macromolecular synthesis in apoptosis
Unlike apoptosis induced by NGF deprivation in sympathetic neurons, which requires de novo protein synthesis, Fas-or TNFmediated cell death is facilitated by the inhibition of macromolecular synthesis. Recently, several groups reported that activation of the Fas and TN F-R1 receptors causes receptor oligomerization, recruitment and activation of procaspase-8, and N-terminal cleavage of BI D; this is followed by translocation of the C-terminal fragment to mitochondria, cytochrome c release, and cell death L uo et al., 1998; Gross et al., 1999) . In light of our findings, we propose that a critical difference between macromolecular synthesis-dependent (e.g., NGF deprivation in sympathetic neurons) and independent (e.g., Fas or TNF treatment in non-neuronal cells) paradigms of cell death may be that the former require the expression of new gene products to induce the translocation of a BH3-domaincontaining, proapoptotic BCL-2 family member to mitochondria, whereas the latter do not. In NGF-deprived sympathetic neurons, BAX alone appears to serve the role of this proapoptotic, BH3-containing protein that mediates the loss of cytochrome c, caspase activation, and cell death (Fig. 8) . In other models of cell death the identity of the proapoptotic, BH3-containing protein responsible for the loss of mitochondrial cytochrome c may vary according to cell type and apoptotic stimulus.
